Literature DB >> 25234519

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Gregory M Lucas1, Michael J Ross2, Peter G Stock3, Michael G Shlipak4, Christina M Wyatt2, Samir K Gupta5, Mohamed G Atta1, Kara K Wools-Kaloustian5, Paul A Pham1, Leslie A Bruggeman6, Jeffrey L Lennox7, Patricio E Ray8, Robert C Kalayjian6.   

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; HIV-associated nephropathy; chronic kidney disease; clinical practice guideline; kidney transplantation

Mesh：

Year:  2014        PMID： 25234519      PMCID： PMC4271038          DOI： 10.1093/cid/ciu617

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  421 in total

1.  Pharmacokinetics of nelfinavir and nevirapine in a patient with end-stage renal failure on continuous ambulatory peritoneal dialysis.

Authors:  S Taylor; J Little; K Halifax; S Drake; D Back
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

2.  Indinavir pharmacokinetics in haemodialysis.

Authors:  H Izzedine; G Aymard; A Hamani; V Launay-Vacher; G Deray
Journal:  Nephrol Dial Transplant       Date:  2000-07       Impact factor: 5.992

3.  Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis.

Authors:  M J Gill; N J Ostrop; W D Fiske; J M Brennan
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

4.  Antiretroviral drug removal by haemodialysis.

Authors:  A M Taburet; L Gerard; M Legrand; G Aymard; J M Berthelot
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

5.  Pharmacokinetics of efavirenz in a patient on maintenance haemodialysis.

Authors:  H Izzedine; G Aymard; V Launay-Vacher; A Hamani; G Deray
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

6.  Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis.

Authors:  D M Grasela; R R Stoltz; M Barry; M Bone; B Mangold; P O'Grady; R Raymond; S J Haworth
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

7.  Is the prevalence of HIV-associated nephropathy decreasing?

Authors:  T S Ahuja; M Borucki; M Funtanilla; V Shahinian; M Hollander; S Rajaraman
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

8.  Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study.

Authors:  Rakhi Khanna; Olympia A Tachopoulou; Paul A Fein; Jyotiprakas Chattopadhyay; Morrell M Avram
Journal:  Adv Perit Dial       Date:  2005

9.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

10.  Current indications for renal biopsy: a questionnaire-based survey.

Authors:  G Fuiano; G Mazza; N Comi; A Caglioti; L De Nicola; C Iodice; M Andreucci; V E Andreucci
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860
View more
  111 in total

Review 1.  Emerging reverse transcriptase inhibitors for HIV-1 infection.

Authors:  Mohammad A Rai; Sam Pannek; Carl J Fichtenbaum
Journal:  Expert Opin Emerg Drugs       Date:  2018-05-10       Impact factor: 4.191

Review 2.  Kidney Disease and HIV Infection.

Authors:  Christina M Wyatt
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

3.  Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications.

Authors:  Kerry M Sheets; Mohamed G Atta; Derek M Fine; Katie Zook; Allison M Mcfall; Michelle M Estrella; George J Schwartz; Gregory M Lucas
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

4.  Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Michael G Shlipak; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael R Bennett; Chirag R Parikh; Joachim H Ix; Vasantha Jotwani
Journal:  Am J Nephrol       Date:  2019-09-25       Impact factor: 3.754

5.  HIV and HCV Medications in End-Stage Renal Disease.

Authors:  Keiko I Greenberg; Mark A Perazella; Mohamed G Atta
Journal:  Semin Dial       Date:  2015-04-06       Impact factor: 3.455

6.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

Review 7.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

8.  Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers.

Authors:  Sarah E Van Pilsum Rasmussen; Mary Grace Bowring; Ashton A Shaffer; Macey L Henderson; Allan Massie; Aaron A R Tobian; Dorry L Segev; Christine M Durand
Journal:  Clin Transplant       Date:  2018-08-31       Impact factor: 2.863

9.  Tenofovir alafenamide as part of a salvage regimen in a patient with multi-drug resistant HIV and tenofovir-DF-associated renal tubulopathy.

Authors:  James M Mikula; Maura M Manion; Frank Maldarelli; Lucila M Suarez; Jaha F Norman-Wheeler; Alex G Ober; Robin L Dewar; Jeffrey B Kopp; H Clifford Lane; Alice K Pau
Journal:  Antivir Ther       Date:  2016-03-08

10.  Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.

Authors:  J F Suarez; R Rosa; M A Lorio; M I Morris; L M Abbo; J Simkins; G Guerra; D Roth; W L Kupin; A Mattiazzi; G Ciancio; L J Chen; G W Burke; M J Goldstein; P Ruiz; J F Camargo
Journal:  Am J Transplant       Date:  2016-04-04       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.